A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS COMPARING ONCE-WEEKLY SEMAGLUTIDE TO CONTROL THERAPY FOR THE TREATMENT OF TYPE 2 DIABETES

被引：1
|
作者：
Pagada, A. [1 ]
Rai, M. K. [1 ]
Khadloya, T. [1 ]
机构：
[1] IQVIA Consulting & Informat Serv India Private Lt, Mumbai, Maharashtra, India
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.07.268
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB3
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [21] Efficacy of Once-Weekly Semaglutide vs Empagliflozin Added to Metformin in Type 2 Diabetes: Patient-Level Meta-analysis
    Lingvay, Ildiko
    Capehorn, Matthew S.
    Catarig, Andrei-Mircea
    Johansen, Pierre
    Lawson, Jack
    Sandberg, Anna
    Shaw, Robert
    Paine, Abby
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (12):
  • [22] Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial
    Lingvay, Ildiko
    Benamar, Malik
    Chen, Liming
    Fu, Ariel
    Jodar, Esteban
    Nishida, Tomoyuki
    Riveline, Jean-Pierre
    Yabe, Daisuke
    Zueger, Thomas
    Rea, Rosangela
    DIABETOLOGIA, 2025, : 739 - 751
  • [23] Once-weekly insulin as novel treatment for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized clinical trials (vol 205, 110984, 2023)
    Soetedjo, Nanny Natalia Mulyani
    Permana, Hikmat
    Hariyanto, Timotius Ivan
    Tendean, Marshell
    Kusumawati, Maya
    Ritonga, Ervita
    Yanto, Theo Audi
    Suastika, Ketut
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 211
  • [24] Efficacy and safety of once-weekly subcutaneous semaglutide on weight loss in patients with overweight or obesity without diabetes mellitus-A systematic review and meta-analysis of randomized controlled trials
    Kommu, Sharath
    Berg, Richard L.
    OBESITY REVIEWS, 2024, 25 (09)
  • [25] Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands
    Hunt, Barnaby
    Malkin, Samuel J. P.
    Moes, Robert G. J.
    Huisman, Eline L.
    Vandebrouck, Tom
    Wolffenbuttel, Bruce H. R.
    BMJ OPEN DIABETES RESEARCH & CARE, 2019, 7 (01)
  • [26] Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Individuals With Obesity or Overweight but Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Moiz, Areesha
    Levett, Jeremy
    Filion, Kristian B.
    Peri, Katya
    Reynier, Pauline
    Eisenberg, Mark J.
    CIRCULATION, 2023, 148
  • [27] Efficacy and safety of once-weekly semaglutide in adults with overweight or obesity: a meta-analysis
    Zhong, Ping
    Zeng, Hai
    Huang, Miaochun
    Fu, Wenbin
    Chen, Zhixia
    ENDOCRINE, 2022, 75 (03) : 718 - 724
  • [28] Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis
    Petri, Kristin Cecilie Carlsson
    Ingwersen, Steen Hvass
    Flint, Anne
    Zacho, Jeppe
    Overgaard, Rune Viig
    DIABETES THERAPY, 2018, 9 (04) : 1533 - 1547
  • [29] Efficacy and safety of once-weekly semaglutide in adults with overweight or obesity: a meta-analysis
    Ping Zhong
    Hai Zeng
    Miaochun Huang
    Wenbin Fu
    Zhixia Chen
    Endocrine, 2022, 75 : 718 - 724
  • [30] Once-weekly exenatide as a treatment for Type 2 diabetes
    Schauerhamer, Marisa B.
    Gurgle, Holly
    McAdam-Marx, Carrie
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (06) : 611 - 626
12345